Introduction: Mixed neuroendocrine non-neuroendocrine neoplasms (MiNEN) have been newly defined in the WHO 2017 classification. They are rare tumors, commonly treated in analogy to their non-neuroendocrine (nNE) or neuroendocrine (NE) component without systematic data regarding the optimal therapeutic strategy.
Aim(s): To analyze the treatment outcomes of MiNEN patients.
Materials and methods: Retrospective analysis of all patients with MiNEN at our center between 10/2001 and 11/2017.
Conference: 15th Annual ENETS conference 2018 (2018)
Category: Epidemiology/Natural history/Prognosis- Registries, nationwide and regional surveys
Presenting Author: Dr. med. Leonidas Apostolidis
To read results and conclusion, please login ...
Further abstracts you may be interested in